Registration is closed.
Course Content
This course provides a clear and structured overview of the entire drug and medical device development process, from early planning to market approval. It highlights the interplay between strategy and development, demonstrating how they influence each other. Participants will gain practical skills to evaluate the risks and benefits of introducing new healthcare products, understand key regulatory requirements in Norway and internationally, and connect with professionals for career growth and collaboration.
Additionally, the course explores specific opportunities for Norwegian researchers to develop pharmaceutical products and expand their businesses. Lectures and course materials will be delivered by leading scientists and entrepreneurs in drug discovery.
Learning Outcomes
By the end of this course, participants will:
- Gain a comprehensive understanding of the drug and medical device development process, from initial strategic planning to commercialization.
- Understand how strategy and development interact and influence each other in drug and device innovation.
- Apply frameworks to assess the risks and benefits of launching new healthcare products.
- Navigate regulatory requirements for product approval in both Norwegian and international markets.
- Identify opportunities for Norwegian researchers to advance drug development and expand their businesses.
- Build a professional network with scientists, entrepreneurs, and industry experts to support career growth and strategic partnerships.
- Learn from leading experts in drug discovery, gaining insights from their experiences and practical knowledge.
- Understand the sequential stages of drug development, from discovery and preclinical testing to clinical trials, regulatory approval, and post-market monitoring.
- Learn the objectives and designs of each clinical trial phase and how they build upon one another to ensure safety and efficacy.
Recommended Prior Knowledge:
The course is designed to accommodate a diverse range of participants interested in drug discovery, including master’s students, PhD candidates, and postdoctoral researchers. To ensure a strong foundation for all attendees, participants must hold a degree in biology or a related field and have a strong interest in the commercialization of scientific research. This inclusive approach fosters a collaborative learning environment where individuals at different stages of their academic and professional journeys can engage with the latest advancements in the field.
The course is supported by the Digital Life Norway Research School and there are a limited number of travel grants available for our members.
Contact:
Aleksandr Anisimov, Nucleate Norway